source
- Daraxonrasib doubles median survival in pancreatic cancer trial, FDA grants early accessAn international study presented at the American Society of Clinical Oncology meeting in Chicago showed that patients with pancreatic cancer who received daraxonrasib lived an average of 13.2 month…
- US launches trade probe into Germany's plan to lower drug pricesUS Department of Commerce announced on June 19, 2026 that it has opened a Section 301 trade investigation targeting Germany’s drug pricing system. The probe follows Germany’s ongoing review of its…